Youtube
SUNPHARMA

Sun Pharmaceutical Industries Ltd Share Price

₹903.9

Score

66

Technically Moderately Bullish

Advice

Sun Pharmaceutical Industries Share Price - 1 Year Trend

Sun Pharmaceutical Industries Price Change Analysis

Sun Pharmaceutical Industries Key Statistics
  • P/E Ratio

    97

  • PEG Ratio

    0.2

  • Market Cap Cr

    216875.9

  • Price to Book Ratio

    113.5

  • EPS

    9.3

  • Dividend

    750 ()

  • Relative Strength Index

    51.38

  • Money Flow Index

    40.12

  • MACD Signal

    -1.85

  • Average True Range

    23.72

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Sun Pharmaceutical Industries Synopsis

NSE-Medical-Generic Drugs

Sun Pharma. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 12803.21 Cr. and Equity Capital is Rs. 239.93 Cr. for the Year ended 31/03/2021. Sun Pharmaceutical Industries Ltd. is a Public Limited Listed company incorporated on 01/03/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1993PLC019050 and registration number is 019050.
  • Market Cap

    216,875.89

  • Sales

    14,399.40

  • Shares in Float

    110.37

  • No of Funds

    935

  • Yield

    1

  • Book Value

    8.66

  • U/D Vol Ratio

    1.1

  • LTDebt/Equity

    19

  • Alpha

    0.11

  • Beta

    0.72

Sun Pharmaceutical Industries Ownership
Sun Pharmaceutical Industries Management

Sun Pharmaceutical Industries Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Sun Pharmaceutical Industries Financials

Sun Pharmaceutical Industries Technicals

EMA & SMA

CURRENT PRICE

EMA

Sun Pharmaceutical Industries Resistance and Support

Sun Pharmaceutical Industries Delivery and Volume

Sun Pharmaceutical Industries Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Sun Pharmaceutical Industries (Sun Pharma) has an operating revenue of INR 36,704.43 Cr. on a trailing 12-month basis. Annual revenue growth of 3% is not great, Pre-tax margin of 8% is okay. Institutional holding has gone up in the last reported quarter is a positive sign. Analyst Recommendation on Sun Pharmaceutical Industries (Sun Pharma): HOLD

Dilip Shanghvi is the Managing Director of Sun Pharmaceutical Industries (Sun Pharma).

The ROE of Sun Pharmaceutical Industries (Sun Pharma) is 6% which is fair but needs improvement.

Sun Pharmaceutical Industries (Sun Pharma) has a reasonable debt to equity of 2%, which signals a healthy balance sheet.

The PE ratio of Sun Pharmaceutical Industries (Sun Pharma) is 81.5.

Sun Pharmaceutical Industries share price is

Open Demat Account